Heidi Cuthbert

OncoSil Medical (ASX:OSL) secured U.S. FDA approval for its OncoSil device to treat distal cholangiocarcinoma, targeting an $80 million market.

Imdex (ASX:IMD) announced record full-year financial results for fiscal 2026, featuring total revenue of $520 million.

XRP (CRYPTO:XRP) ETFs recorded $2.25 million in net inflows last week, according to SoSoValue data.

Tokenisation-related stocks fell on Friday after the SEC delayed a planned exemption for tokenised securities.

Growthpoint Properties Australia (ASX:GOZ) returned to profitability in FY26, reporting a statutory net profit of $90.1 million.

Hancock Prospecting purchased eight million shares of SpaceX (NASDAQ:SPCX) for US$1.37 billion to expand its US footprint.

Audinate (ASX:AD8) reported FY26 revenue of US$46 million, rising 14.9% from the prior year of US$40 million.

DeFiLlama delayed its mobile app launch after fake apps impersonating the platform appeared on Apple’s App Store.

GPT Group (ASX:GPT) recorded a $400.1 million statutory net profit for the half-year.

Treasurer Jim Chalmers rejected One Nation policies that propose early superannuation access and a 130,000 annual migration cap.